The menin inhibitor market is poised for rapid growth, with REVUFORJ setting the foundation and a strong pipeline of innovative, genetically targeted therapies on the horizon.With high levels of unmet …
Tag:
Medical Pharmaceuticals
-
-
According to DelveInsight’s analysis, the Lewy body dementia market is anticipated to increase during the forecast period (2025-2034), owing to the launch of emerging therapies such as Neflamapimod (CervoMed), Zervimesine …
-
World
IASO Bio Celebrates Grand Opening of Shanghai Waigaoqiao Global R&D Center and Successfully Hosts Forum on China’s Cell Therapy Globalization
SHANGHAI, NANJING, and SAN FRANCISCO, May 20, 2025 /PRNewswire/ — IASO Biotherapeutics (“IASO Bio”), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative cell therapies and …
-
RND Automation (RND), a subsidiary of CAS Holdings (CAS), is excited to announce the successful acquisition of QuickPouch’s intellectual property and assets. LAKEWOOD RANCH, Fla., April 18, 2025 /PRNewswire/ — …
Older Posts